CLINICAL_TRIALS
trial_result
· 2026-03-10
Clinical Trial Update: Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy [Phase 3]
Summary
Phase 3 trial update presenting long-term outcomes for ataluren in Duchenne muscular dystrophy; results were posted in March 2026.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Muscular Dystrophy, Duchenne, Muscular Dystrophies | Phase 3 | Status: COMPLETED | Results posted: 2026-03-10